Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Myeloid-Derived Suppressor Cells in Solid Tumors
Tianmiao Ma, Bernhard W. Renz, Matthias Ilmer, et al.
Cells (2022) Vol. 11, Iss. 2, pp. 310-310
Open Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

Myeloid-derived suppressor cells in cancer and cancer therapy
Samantha Lasser, Feyza Gül Özbay Kurt, Ihor Arkhypov, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 2, pp. 147-164
Closed Access | Times Cited: 116
Allogeneic natural killer cell therapy
Melissa M. Berrien-Elliott, Miriam T. Jacobs, Todd A. Fehniger
Blood (2022) Vol. 141, Iss. 8, pp. 856-868
Open Access | Times Cited: 109
Recent Advances and Challenges in Cancer Immunotherapy
Chelsea Peterson, Nathan Denlinger, Yiping Yang
Cancers (2022) Vol. 14, Iss. 16, pp. 3972-3972
Open Access | Times Cited: 74
The Roles of Epigenetic Regulation and the Tumor Microenvironment in the Mechanism of Resistance to Systemic Therapy in Hepatocellular Carcinoma
Kyoko Oura, Asahiro Morishita, Sae Hamaya, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2805-2805
Open Access | Times Cited: 25
Myeloid‑derived suppressor cells: Key immunosuppressive regulators and therapeutic targets in colorectal cancer (Review)
Wenjuan Zeng, Haohan Liu, Yuanhao Mao, et al.
International Journal of Oncology (2024) Vol. 65, Iss. 3
Closed Access | Times Cited: 10
Neuroscience in peripheral cancers: tumors hijacking nerves and neuroimmune crosstalk
Hua‐yang Fan, Xin‐hua Liang, Ya‐ling Tang
MedComm (2024) Vol. 5, Iss. 11
Open Access | Times Cited: 6
IRF8: Mechanism of Action and Health Implications
Hannah R. Moorman, Yazmin Reategui, Dakota B. Poschel, et al.
Cells (2022) Vol. 11, Iss. 17, pp. 2630-2630
Open Access | Times Cited: 23
The tumor microenvironment of hepatocellular carcinoma and its targeting strategy by CAR-T cell immunotherapy
Guizhen Zhang, Ji Guanchang, Liwen Liu, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 23
ROS regulation in gliomas: implications for treatment strategies
Yuchen Yang, Yu Zhu, Si-Jia Sun, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13
Navigating the Immune Maze: Pioneering Strategies for Unshackling Cancer Immunotherapy Resistance
Liqin Yao, Qingqing Wang, Wenxue Ma
Cancers (2023) Vol. 15, Iss. 24, pp. 5857-5857
Open Access | Times Cited: 13
Monocytic myeloid-derived suppressor cells contribute to the exacerbation of bone destruction in periodontitis
Zhaocai Zhou, Chi Zhan, Wenchuan Li, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Amelioration of imiquimod induced psoriasis through reduction in IL-17A and Th17 population by dihydromyricetin involves regulation of RORγt pathway
Debanjan Sarkar, Anik Pramanik, Jayasree Saha, et al.
International Immunopharmacology (2025) Vol. 153, pp. 114492-114492
Closed Access
The Role of Tumor Microenvironment in Invasion and Metastasis of Esophageal Squamous Cell Carcinoma
Shuyue Zheng, Beilei Liu, Xin‐Yuan Guan
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 19
The role of myeloid-derived suppressor cells in liver cancer
Shiyue Zhou, Zixuan Zhao, Hao Zhong, et al.
Discover Oncology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 12
Single-cell analysis defines highly specific leukemia-induced neutrophils and links MMP8 expression to recruitment of tumor associated neutrophils during FGFR1 driven leukemogenesis
Tianxiang Hu, Bo Cheng, Atsuko Matsunaga, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 4
SLAM family-mediated crosstalk between tumor and immune cells in the tumor microenvironment: a promising biomarker and a potential therapeutic target for immune checkpoint therapies
Louis Boafo Kwantwi
Clinical & Translational Oncology (2024) Vol. 27, Iss. 3, pp. 901-908
Closed Access | Times Cited: 4
HIV Latency in Myeloid Cells: Challenges for a Cure
Alisha Chitrakar, Marta Sanz, Sanjay B. Maggirwar, et al.
Pathogens (2022) Vol. 11, Iss. 6, pp. 611-611
Open Access | Times Cited: 18
Decreased melanoma CSF-1 secretion by Cannabigerol treatment reprograms regulatory myeloid cells and reduces tumor progression
Iris Wyrobnik, Miryam Steinberg, Anat Gelfand, et al.
OncoImmunology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 9
Chimeric antigen receptor-modified T cells therapy in prostate cancer: A comprehensive review on the current state and prospects
Mingze He, Dongqi Zhang, Yu Cao, et al.
Heliyon (2023) Vol. 9, Iss. 8, pp. e19147-e19147
Open Access | Times Cited: 9
IPIAD- an augmentation regimen added to standard treatment of pancreatic ductal adenocarcinoma using already-marketed repurposed drugs irbesartan, pyrimethamine, itraconazole, azithromycin, and dapsone
Richard E. Kast
Oncoscience (2024) Vol. 11, pp. 15-31
Open Access | Times Cited: 3
Modulation of myeloid-derived suppressor cell functions by oral inflammatory diseases and important oral pathogens
Fernando García-Arévalo, Ana Gabriela Leija-Montoya, Javier González-Ramírez, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Prospects of Synergy: Local Interventions and CAR T Cell Therapy in Solid Tumors
Anne Holtermann, Mila Gislon, Martin K. Angele, et al.
BioDrugs (2024) Vol. 38, Iss. 5, pp. 611-637
Open Access | Times Cited: 3
Present and Future of Immunotherapy for Triple-Negative Breast Cancer
Sushmitha Sriramulu, Shivani Thoidingjam, Corey Speers, et al.
(2024)
Open Access | Times Cited: 3
The prospect of tumor microenvironment-modulating therapeutical strategies
Dirk Eulberg, Anna Frömming, Kfir Lapid, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 13
Targeting the oral tumor microenvironment by nanoparticles: A review of progresses
Haosheng Zhang, Fangzheng Zhou, Qiuyu Yang, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 91, pp. 105248-105248
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top